Syndax Pharmaceuticals SNDX Depreciation And Related Adjustment
Depreciation And Related Adjustment at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept sndx:DepreciationAndRelatedAdjustment.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's depreciation and related adjustment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's depreciation and related adjustment?
- Syndax Pharmaceuticals (SNDX) reported depreciation and related adjustment of $4K in Q1 2026.
- What is the long-term trend for Syndax Pharmaceuticals's depreciation and related adjustment?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's depreciation and related adjustment has grown at a -38.9% compound annual growth rate (CAGR), from $43K to $6K.
- What does depreciation and related adjustment mean?
- This represents the non-cash charge recorded to allocate the cost of tangible assets over their useful lives. It reflects the wear and tear or obsolescence of property, plant, and equipment used in the company's clinical and operational activities.